ADAURA results: Adjuvant osimertinib for EGFRm non-small cell lung cancer

COVID-19: Treating breast cancer and the knock on effects of the coronavirus pandemic

Pembrolizumab plus chemotherapy for patients with metastatic triple-negative breast cancer

COM701 as a monotherapy and in combination with nivolumab for various advanced solid tumours

Conducting Oncology Clinical Trials in Africa II: AC3T - Assessing, profiling, and building cancer clinical trial capacity in Africa

Perioperative use of NSAIDs reduces risk of early relapse in breast cancer

Do immune checkpoint inhibitors work in EGFR mutant lung cancer?

Diagnosing, treating and managing breast cancer during COVID-19

COVID-19: Risk of millions relapsing back to smoking

COVID-19: Using oncology drugs and surgery during the coronavirus pandemic

TERAVOLT: Thoracic cancers indicate an unexpectedly high mortality rate in patients with COVID-19

IMPRIME 1: Combination of pembrolizumab and a novel innate immune activator, Imprime PGG, in second-line mTNBC